Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by guildwood1on Mar 11, 2015 2:56pm

84 Views

Post# 23510652

RE:RE:Less than 250mg daily?

Sorry should have clairified that last one was directed to Birch1

Lmao actually it is. Do some DD. ATB364 is an NSAID same as Asprin's active ingredient just ATB364 utilizes a different oxidation delivery method however it appears to cause potential hepotoxicity in any effective dose. Keep talking idiot.
Read more at https://www.stockhouse.com/companies/bullboard/v.ate/antibe-therapeutics-inc#kVEADmQiCSbC6dP3.99

birch1 wrote: LOL. So by that analogy, ingesting 250mg of uranium is less powerfull thatn an extra strenght Aspirin.

Really? 250mg of ATB 364 and 250mg of Aspirin are not the same thing dude.

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale